MedPath

VICARI STEFANO

🇮🇹Italy
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome

Phase 2
Recruiting
Conditions
Down Syndrome
Interventions
Drug: Placebo
First Posted Date
2024-06-20
Last Posted Date
2024-06-20
Lead Sponsor
Stefano Vicari
Target Recruit Count
64
Registration Number
NCT06465823
Locations
🇮🇹

Bambino Gesù Children's Hospital, Rome, Italy

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.